Covered recipient · General Payments record
STACIA LYNNE GALLION
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$3,725.17
- Reported across 174 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $955.71 | 50 |
| Education | $390.84 | 5 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $152.51 | 8 |
| Exelixis Inc. | $138.56 | 4 |
| Astellas Pharma US Inc | $118.50 | 2 |
| Incyte Corporation | $107.27 | 2 |
| SANOFI-AVENTIS U.S. LLC | $99.95 | 1 |
| Daiichi Sankyo Inc. | $78.50 | 4 |
| ABBVIE INC. | $65.19 | 3 |
| Merck Sharp & Dohme Corporation | $64.53 | 4 |
| Acerta Pharma LLC | $57.44 | 3 |
| Janssen Biotech, Inc. | $48.49 | 2 |
| Regeneron Healthcare Solutions, Inc. | $44.88 | 2 |
| BeiGene USA, Inc. | $40.65 | 2 |
| Lilly USA, LLC | $34.36 | 2 |
| GlaxoSmithKline, LLC. | $30.52 | 2 |
| GENZYME CORPORATION | $29.81 | 1 |
| Pharmacosmos Therapeutics Inc. | $28.77 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.05 | 1 |
| Alexion Pharmaceuticals, Inc. | $21.88 | 1 |
| Mirati Therapeutics, Inc. | $21.53 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.64 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $19.19 | 1 |
| Stemline Therapeutics Inc. | $17.87 | 1 |
| Gilead Sciences, Inc. | $17.47 | 1 |
| Dendreon Pharmaceuticals LLC | $16.98 | 1 |
| EISAI INC. | $16.38 | 1 |
| TAIHO ONCOLOGY, INC. | $15.82 | 1 |
| Ipsen Biopharmaceuticals, Inc | $14.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (55)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.